The Registry Study to Compare the Cardiopulmonary Exercise Test Parameters Before and After Cardiac Rehabilitation in Patients With Chronic Total Occlusion of the Coronary Arteries

July 16, 2017, 9:00 am

≫ Next: Very Low Carbohydrate Diet Effects to GPS, Serum Lactate and TNF Alpha on Colorectal Cancer

≪ Previous: Pars Plana Vitrecromy in Patients Aged 85 Years and Above

$

0

0

Conditions:   Coronary Artery Disease;   Total Occlusion of Coronary Artery
Intervention:   Behavioral: cardiac rehabilitation
Sponsor:   Seung-Jung Park
Not yet recruiting - verified July 2017

---

Very Low Carbohydrate Diet Effects to GPS, Serum Lactate and TNF Alpha on Colorectal Cancer

July 16, 2017, 9:00 am

≫ Next: Natural History in Fabry Patients With IVS4+919G>A Mutation

≪ Previous: The Registry Study to Compare the Cardiopulmonary Exercise Test Parameters Before and After Cardiac Rehabilitation in Patients With Chronic Total Occlusion of the Coronary Arteries

$

0

0

Conditions:   Diet Modification;   Colorectal Adenocarcinoma;   Systemic Inflammation;   TNF Alpha;   Lactate
Intervention:   Other: Very Low Carbohydrate Diet
Sponsor:   Dr. Soetomo General Hospital
Not yet recruiting - verified July 2017

Natural History in Fabry Patients With IVS4+919G>A Mutation

July 16, 2017, 9:00 am

≫ Next: Catheter Salvage in Intestinal Failure Patients

≪ Previous: Very Low Carbohydrate Diet Effects to GPS, Serum Lactate and TNF Alpha on Colorectal Cancer

$

0

0

Condition:   Fabry Disease, Cardiac Variant
Intervention:   Behavioral: Family pedigree and data collection
Sponsors:   Taipei Veterans General Hospital, Taiwan;   Sanofi
Not yet recruiting - verified July 2017

Catheter Salvage in Intestinal Failure Patients

July 16, 2017, 9:00 am

≫ Next: The Impact of Exercise Training on Living Quality in Multiple Sclerosis Individuals

≪ Previous: Natural History in Fabry Patients With IVS4+919G>A Mutation

$

0

0

Conditions:   Intestinal Failure;   Catheter-Related Bloodstream Infection (CRBSI) Nos
Intervention:   Behavioral: catheter salvage
Sponsor:   Rigshospitalet, Denmark
Completed - verified July 2017

The Impact of Exercise Training on Living Quality in Multiple Sclerosis Individuals

July 16, 2017, 9:00 am

≫ Next: A Study Evaluating Tolerability and Efficacy of Navitoclax in Combination With Ruxolitinib in Subjects With Myelofibrosis

≪ Previous: Catheter Salvage in Intestinal Failure Patients

$

0

0

Conditions:   Multiple Sclerosis;   Fatigue;   Mental Status Change;   Physical Disability;   Physical Activity;   Mental Impairment;   Quality of Life;   Disabilities Psychological;   Disability Physical;   Pain;   Energy Supply; Deficiency;   Motivation
Intervention:   Behavioral: Exercise training
Sponsor:   Tanja Grubic Kezele
Recruiting - verified July 2017

A Study Evaluating Tolerability and Efficacy of Navitoclax in Combination With Ruxolitinib in Subjects With Myelofibrosis

July 17, 2017, 9:00 am

≫ Next: Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)

≪ Previous: The Impact of Exercise Training on Living Quality in Multiple Sclerosis Individuals

$

0

0

Condition:   Myelofibrosis (MF)
Intervention:   Drug: Navitoclax
Sponsor:   AbbVie
Not yet recruiting - verified July 2017

Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)

July 17, 2017, 9:00 am

≫ Next: Perineural Dexmedetomidine for Ulnar Nerve Block.

≪ Previous: A Study Evaluating Tolerability and Efficacy of Navitoclax in Combination With Ruxolitinib in Subjects With Myelofibrosis

$

0

0

Condition:   Multiple Sclerosis
Interventions:   Drug: BIIB033;   Drug: Placebo
Sponsor:   Biogen
Not yet recruiting - verified June 2017

Perineural Dexmedetomidine for Ulnar Nerve Block.

July 17, 2017, 9:00 am

≫ Next: A Study to Evaluate the Effect of a Potent Cytochrome P450 (CYP) 3A Inhibitor on Ipatasertib

≪ Previous: Efficacy and Safety of BIIB033 as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)

$

0

0

Condition:   Healthy
Interventions:   Drug: Dexmedetomidine perineurally;   Drug: Ropivacaine 5mg/ml;   Drug: Ropivacaine 7.5mg/ml;   Drug: Dexmedetomidine systemically;   Drug: Isotonic saline
Sponsor:   Zealand University Hospital
Recruiting - verified July 2017

---

A Study to Evaluate the Effect of a Potent Cytochrome P450 (CYP) 3A Inhibitor on Ipatasertib

July 17, 2017, 9:00 am

≫ Next: Brentuximab Vedotin for Systemic Sclerosis

≪ Previous: Perineural Dexmedetomidine for Ulnar Nerve Block.

$

0

0

Condition:   Healthy Volunteers
Interventions:   Drug: Ipatasertib;   Drug: Itraconazole
Sponsor:   Hoffmann-La Roche
Recruiting - verified July 2017

Brentuximab Vedotin for Systemic Sclerosis

July 17, 2017, 9:00 am

≫ Next: The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

≪ Previous: A Study to Evaluate the Effect of a Potent Cytochrome P450 (CYP) 3A Inhibitor on Ipatasertib

$

0

0

Conditions:   Diffuse Cutaneous Systemic Sclerosis;   Scleroderma;   dcSSc
Interventions:   Biological: Brentuximab Vedotin;   Biological: Placebo
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN);   Seattle Genetics, Inc.
Not yet recruiting - verified July 2017

The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

July 17, 2017, 9:00 am

≫ Next: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

≪ Previous: Brentuximab Vedotin for Systemic Sclerosis

$

0

0

Condition:   Diabetes Mellitus, Type 2
Intervention:   Device: Cornerstones4Care Powered by Glooko App
Sponsors:   Healthcare Innovation Technology Lab;   Novo Nordisk A/S
Recruiting - verified July 2017

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

July 17, 2017, 9:00 am

≫ Next: Prospective Endoscopic Follow-up of Patients With Submucosal Esophageal Adenocarcinoma (The PREFER Trial)

≪ Previous: The Usability, Acceptability, and Perceived Value of the Cornerstones4Care Powered by Glooko App

$

0

0

Condition:   Hepatitis C Virus (HCV)
Interventions:   Drug: ABT-493/ABT-530;   Drug: Placebo
Sponsor:   AbbVie
Not yet recruiting - verified July 2017

Prospective Endoscopic Follow-up of Patients With Submucosal Esophageal Adenocarcinoma (The PREFER Trial)

July 17, 2017, 9:00 am

≫ Next: Non-invasive Versus Invasive Blood Pressure Measurement in the Super Morbidly Obese Parturient With Severe Preeclampsia

≪ Previous: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Treatment-Naïve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection

$

0

0

Conditions:   Submucosal Esophageal Adenocarcinoma;   Barrett Esophagus
Intervention:   Procedure: Endoscopic follow-up
Sponsor:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Recruiting - verified July 2017

Non-invasive Versus Invasive Blood Pressure Measurement in the Super Morbidly Obese Parturient With Severe Preeclampsia

July 17, 2017, 9:00 am

≫ Next: Implant Insertion Torque and Primary Stability

≪ Previous: Prospective Endoscopic Follow-up of Patients With Submucosal Esophageal Adenocarcinoma (The PREFER Trial)

$

0

0

Conditions:   Pre-Eclampsia;   Morbid Obesity;   Parturient;   Blood Pressure
Interventions:   Device: Non-invasive BP recording with conical Ultracheck Curve BP cuff;   Device: Non-invasive BP recording with traditional cylindrical BP cuff;   Other: Direct invasive arterial pressure
Sponsor:   Vanderbilt University Medical Center
Recruiting - verified July 2017

Implant Insertion Torque and Primary Stability

July 17, 2017, 9:00 am

≫ Next: HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals

≪ Previous: Non-invasive Versus Invasive Blood Pressure Measurement in the Super Morbidly Obese Parturient With Severe Preeclampsia

$

0

0

Condition:   DENTAL IMPLANTATION
Intervention:   Procedure: dental implant insertion
Sponsor:   International Piezosurgery Academy
Recruiting - verified July 2017

---

HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals

July 17, 2017, 9:00 am

≫ Next: Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring

≪ Previous: Implant Insertion Torque and Primary Stability

$

0

0

Condition:   Cervical Cancer Screening
Intervention:   Behavioral: HPV self-sampling
Sponsor:   University of Miami
Recruiting - verified July 2017

Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring

July 17, 2017, 9:00 am

≫ Next: A Crowdsourced Social Media Portal for Parents of Very Young Children With Type 1 Diabetes

≪ Previous: HPV Self-Sampling for Cervical Cancer Screening Among Transgender Men and Transmasculine Individuals

$

0

0

Condition:   Snoring
Intervention:   Device: TRP
Sponsor:   Tongue Laboratory
Recruiting - verified July 2017

A Crowdsourced Social Media Portal for Parents of Very Young Children With Type 1 Diabetes

July 17, 2017, 9:00 am

≫ Next: Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b

≪ Previous: Efficacy Study of the Medical Device TRP Snorless™ in the Treatment of Snoring

$

0

0

Condition:   Type 1 Diabetes Mellitus
Intervention:   Behavioral: Website
Sponsors:   Nemours Children's Clinic;   University of Colorado, Denver
Not yet recruiting - verified July 2017

Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b

July 17, 2017, 9:00 am

≫ Next: EFFECTS OF SHOCK WAVE THERAPY IN MIOFASCIAL PAIN

≪ Previous: A Crowdsourced Social Media Portal for Parents of Very Young Children With Type 1 Diabetes

$

0

0

Conditions:   Chronic Hepatitis C Genotype 1B;   Metabolic Syndrome;   Fibrosis, Liver;   Cirrhoses, Liver
Intervention:   Drug: Elbasvir/ Grazoprevir 50/100 mg fixed dose combination
Sponsors:   Institute Of Cardiology & Internal Diseases, Kazakhstan;   Schering-Plough;   Synergy Research Group
Not yet recruiting - verified July 2017

EFFECTS OF SHOCK WAVE THERAPY IN MIOFASCIAL PAIN

July 17, 2017, 9:00 am

≫ Next: The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - PARTNER II - High Risk and Nested Registry 7

≪ Previous: Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b

$

0

0

Conditions:   Pain;   Muscle Tonus
Interventions:   Device: Experimental - Shock wave therapy;   Device: Placebo - Shock wave therapy
Sponsors:   Rodrigo Marcel Valentim da Silva;   Universidade Federal do Rio Grande do Norte
Completed - verified July 2017